|
| 36416860 | Set1 regulates telomere function via H3K4 methylation-dependent and -independent pathways and calibrates the abundance of telomere maintenance factors. | Mol Biol Cell | 2023 |
| 34320248 | Adaptive local false discovery rate procedures for highly spiky data and their application RNA sequencing data of yeast SET4 deletion mutants. | Biom J | 2021 |
| 34816128 | Immunoaffinity purification of endogenous proteins from <i>S. cerevisiae</i> for post-translational modification and protein interaction analysis. | STAR Protoc | 2021 |
| 34625508 | Set4 regulates stress response genes and coordinates histone deacetylases within yeast subtelomeres. | Life Sci Alliance | 2021 |
| 31685550 | Function of the MYND Domain and C-Terminal Region in Regulating the Subcellular Localization and Catalytic Activity of the SMYD Family Lysine Methyltransferase Set5. | Mol Cell Biol | 2020 |
| 31642774 | Using Yeast to Define the Regulatory Role of Protein Lysine Methylation. | Curr Protein Pept Sci | 2020 |
| 30523388 | SET domains and stress: uncovering new functions for yeast Set4. | Curr Genet | 2019 |
| 30800719 | Assessing Yeast Cell Survival Following Hydrogen Peroxide Exposure. | Bio Protoc | 2019 |
| 30823596 | Histone Modifications and the Maintenance of Telomere Integrity. | Cells | 2019 |
| 29353165 | Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database. | Eur J Cancer | 2018 |
| 30082318 | Set4 is a chromatin-associated protein, promotes survival during oxidative stress, and regulates stress response genes in yeast. | J Biol Chem | 2018 |
| 27911222 | The histone methyltransferases Set5 and Set1 have overlapping functions in gene silencing and telomere maintenance. | Epigenetics | 2017 |
| 29364237 | Chromatin Immunoprecipitation (ChIP) of Histone Modifications from Saccharomyces cerevisiae. | J Vis Exp | 2017 |
| 29066473 | Repression of Middle Sporulation Genes in <i>Saccharomyces cerevisiae</i> by the Sum1-Rfm1-Hst1 Complex Is Maintained by Set1 and H3K4 Methylation. | G3 (Bethesda) | 2017 |
| 27769718 | Choose Your Own Adventure: The Role of Histone Modifications in Yeast Cell Fate. | J Mol Biol | 2017 |
| 24442241 | Set5 and Set1 cooperate to repress gene expression at telomeres and retrotransposons. | Epigenetics | 2014 |
| 24590654 | Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. | J Clin Oncol | 2014 |
| 24309976 | Proteome-wide enrichment of proteins modified by lysine methylation. | Nat Protoc | 2014 |
| 23059506 | Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing: a report from the prospective COST trial. | Ann Surg | 2013 |
| 24068973 | The molecular mechanism of a cis-regulatory adaptation in yeast. | PLoS Genet | 2013 |
| 23733765 | Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database. | J Clin Oncol | 2013 |
| 22343720 | Methylation of H4 lysines 5, 8 and 12 by yeast Set5 calibrates chromatin stress responses. | Nat Struct Mol Biol | 2012 |
| 23505394 | Everybody's welcome: The big tent approach to epigenetic drug discovery. | Drug Discov Today Ther Strateg | 2012 |
| 22688645 | New marks on the block: Set5 methylates H4 lysines 5, 8 and 12. | Nucleus | 2012 |
| 22614981 | Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data set. | J Clin Oncol | 2012 |
| 22323286 | A negative feedback loop at the nuclear periphery regulates GAL gene expression. | Mol Biol Cell | 2012 |
| 20944015 | Overlapping regulation of CenH3 localization and histone H3 turnover by CAF-1 and HIR proteins in Saccharomyces cerevisiae. | Genetics | 2011 |
| 21816341 | CUL4B: trash talking at chromatin. | Mol Cell | 2011 |
| 21681382 | Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group. | Ann Surg Oncol | 2011 |
| 21422438 | Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. | J Clin Oncol | 2011 |
| 20378639 | Dipstick tests for secondhand smoke exposure. | Nicotine Tob Res | 2010 |
| 20729254 | Cancer registries: a novel alternative to long-term clinical trial follow-up based on results of a comparative study. | Clin Trials | 2010 |
| 20530282 | Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741. | J Clin Oncol | 2010 |
| 20555324 | Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans. | Nature | 2010 |
| 19124803 | Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. | J Clin Oncol | 2009 |
| 19636001 | Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. | J Clin Oncol | 2009 |
| 19622902 | Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147. | Oncology | 2009 |
| 19828593 | NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial. | Oncologist | 2009 |
| 19564531 | Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. | J Clin Oncol | 2009 |
| 18349286 | Comparative bioavailability of sulindac in capsule and tablet formulations. | Cancer Epidemiol Biomarkers Prev | 2008 |
| 19073970 | Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. | Clin Cancer Res | 2008 |
| 18948801 | Surgeon volume does not predict outcomes in the setting of technical credentialing: results from a randomized trial in colon cancer. | Ann Surg | 2008 |
| 18285438 | Surrogate endpoint validation: statistical elegance versus clinical relevance. | Stat Methods Med Res | 2008 |
| 17687151 | Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741. | J Clin Oncol | 2007 |
| 17893502 | Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. | Ann Surg | 2007 |
| 17876008 | End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. | J Clin Oncol | 2007 |
| 16943526 | Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. | J Clin Oncol | 2006 |
| 15677624 | Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. | Ann Oncol | 2005 |
| 16303565 | Replication-independent histone deposition by the HIR complex and Asf1. | Curr Biol | 2005 |
| 16260700 | Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. | J Clin Oncol | 2005 |